Our history is full of important milestones on our way to sustainable success

OUR STORY

The founding of SCOPE International AG in 2000 developed from close working partnerships established years prior. Many of our employees share more than 20 years of experience working together in international clinical research.

As the company is privately owned, SCOPE enjoys unparalleled freedom that allows for independent and strategic decision making. This contributes to the outstanding stability of the company itself and creates an environment of trust, facilitating long-term collaborations and supporting your clinical development plans from set-up to completion. Furthermore, our joint responsibility enables us to work as an efficient and committed team.

Over the years we have expanded our locations and set up new branches with permanently employed staff in Eastern, Western Europe and the USA. It’s an approach that has been driven by our sponsor’s requirements – many of whom have been with us since inception.

Today, SCOPE is an established full-service CRO with 17 offices and approximately 250 employees covering more than 30 countries enabling access to key patient populations and investigators in both routine and rare indications.

2019 | Marketing Authorization

Marketing authorisation granted for a contraceptive pill in the US.

2018 | Technology

SCOPE’s new e-signature feature launched.

2017 | Marketing authorisation

Marketing authorisation granted for an anticonvulsant for peadiadric indication in the US (epilepsy).

2016 | Marketing authorisation

Marketing authorisation granted for a COMT inhibitor in Europe (Parkinson).

2016 | Technology

Launch of our InSIGHT application, which is a proprietary innovative clinical trial management system (CTMS).

2015 | United States of America

Opening of a new office in Pittsburgh, Pennsylvania, US, start of our expansion with our own staff to the Americas.    

2013 | Technology

Launch of SCOPE’s application for centralized automated electronic safety reporting (SCORIS).

2013 | Technology

Conception and start of KaleidoSCOPE development – a central portal covering several software solutions: including Safety Reporting (SCORIS) and CTMS (inSIGHT)    

2013 | United Kingdom

New office opening in Manchester, UK continuing our expansion in Western Europe.

2013 | Marketing authorisation

Marketing authorisation granted for an innovative new inhalation device for patients with asthma and/or chronic obstructive pulmonary disease (COPD) in Europe.

2013 | Extension office facilities

Further extension of SCOPE International’s Mannheim headquarters in Germany.

2013 | Marketing authorisation

Marketing authorisation granted for an anticonvulsant in the US (epilepsy).

2010 | Marketing authorisation

Marketing authorisation granted for an opioid in the US (moderate to severe pain relief).

2010 | Extension office facilities

10 year anniversary of SCOPE International and extension of headquarters in Mannheim, Germany.

2010 | Marketing authorisation

Marketing authorisation granted for an opioid in Europe (moderate to severe pain relief).

2009 | Marketing authorisation

Marketing authorisation granted for an anticonvulsant (epilepsy) in Europe.

2008 | Italy, Spain, Portugal

New office opening in Milan, Italy and Barcelona, Spain (covering Portugal with local based CRAs).

2007 | Bulgaria, Serbia

Continuing our organic expansion into Eastern Europe with new offices opening in Sofia, Bulgaria and Belgrade, Serbia.

2005 | New office facilities

New head office building in Mannheim, Germany.

2004 | Slovakia

Opening of a new office in Rimavská Sobota, Slovakia.

2004 | Marketing authorisation

Marketing authorisation granted for a long-acting beta-agonist (asthma).

2002 | Marketing authorisation

Marketing authorisation granted for an anti-infective drug (pneumology).

2002 | France

New French office opened in Paris, beginning our expansion across Western Europe providing a local service to this important Market.

2001 | Romania, Croatia, Czech Republic

Opening of Romanian (Bucharest), Croatian (Zagreb) and Czech (Praha) offices, marked the beginning of our expansion into Eastern Europe.

2000 | SCOPE incorporation

The incorporation of SCOPE International AG as an independent CRO and peoples company, was a natural progression of a team of colleagues working closely together.

1998 | Hungary

Opening of the Hungarian office in the capital city Budapest.

1997 | Poland

Opening of the Polish office in Krakow, the second biggest city of the country.

1996 | Russia, Ukraine

Opening of the Russian and Ukrainian offices in the capital cities Moscow and Kiev.

1993 | Lithuania

Opening of the Lithuanian office in the capital city Vilnius.

1992 | Germany

Start of pre-SCOPE business in Mannheim, Germany.